First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

Babiker, Abdel ; Castro nee Green, Hannah ; Compagnucci, Alexandra ; Fiscus, Susan ; Giaquinto, Carlo ; Gibb, Diana M ; Harper, Lynda ; Harrison, Linda ; Hughes, Michael ; McKinney, Ross ; Melvin, Ann ; Mofenson, Lynne ; Saidi, Yacine ; Smith, M Elizabeth ; Tudor-Williams, Gareth ; Walker, A Sarah

The Lancet infectious diseases, 2011-04, Vol.11 (4), p.273-283 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível